Standard Life Investments Ignis Hig
|Bid Price||GBX 221.89||Offer Price||GBX 231.74|
|Mid Price||-||Day Change||GBX +1.13 (0.51%)|
|Price Date||22 Oct 2015||Crown Rating|
|Shares Class||Inc.||Yield||4.21 %|
|Total Expense Ratio||1.36||Fund Size||27,500,000.00|
|Launch Date||14/02/2000||Standard Initial Charge (%)||4.25|
|Annual Management Charge (%)||1.25||Sector||IMA UK Equity Income|
|Min Investment (£)||500.00||Total Expense Ratio (%)||1.36|
|ISIN||GB0009515957||Min TopUp (£)||250.00|
To achieve a yield in excess of that available through investment in a traditional corporate bond fund. Also, to pursue a policy of active management through a diversified portfolio and rigorous stock selection to control the impact of credit risks on capital values.
Fraser joined Standard Life Investments in 2011 and is an Investment Director in the Credit team. He is the Lead Manager of the Ignis High Income Fund and also has responsibility for companies specialising in the Healthcare and Pharmaceutical sectors across the full bond spectrum. Previously, Fraser spent four years at Lehman Brothers as analyst and industry specialist for the Healthcare, Pharmaceuticals, and Chemicals sectors. He also worked for Deloitte, Edinburgh as an Assistant Manager in Assurance & Advisory Department. Fraser has 12 years’ experience in the industry, is a CFA Charterholder, a Chartered Accountant (CA) and holds a PhD in synthetic organic chemistry from Heriot-Watt University.